Regarding new vaccines against infection with M.tb, recombinant MVA expressing Ag85A (MVA85A) has been shown to boost and improve protection of BCG in mice, cattle and rhesus monkeys and to induce both CD4 and CD8 T cells [23], [24], [25]. Here, CD8A is linked to infection.